Stock events for Health Catalyst, Inc. (HCAT)
Daniel Burton announced he would step down as CEO in August 2025, with retirement planned for June 30, 2026. Health Catalyst released its Q3 2025 earnings in November 2025, reporting an EPS of $0.06 and quarterly revenue of $76.32 million, both exceeding expectations. Several insider stock transactions occurred in December 2025, primarily sales by executives and directors. In January 2026, the company pre-released its Q4 2025 results, with revenue slightly above consensus and EBITDA in line with expectations. Stifel reiterated a "Buy" rating for HCAT in January 2026, with a $3.75 price target, despite mixed forward guidance. A buy signal was issued in February 2026, and the stock rose 2.87%. The stock has experienced volatility and holds sell signals from both short and long-term Moving Averages. The stock price has decreased by 95.86% over the past 5 years.
Demand Seasonality affecting Health Catalyst, Inc.’s stock price
The first quarter (Q1) is typically a softer quarter for bookings for Health Catalyst. Despite this seasonality, Health Catalyst added 10 net new platform clients in Q1 2025, indicating a positive underlying demand situation.
Overview of Health Catalyst, Inc.’s business
Health Catalyst, Inc. operates in the Healthcare sector, providing data and analytics technology and services to healthcare organizations. Its products and services include the cloud-based Health Catalyst Ignite ecosystem, analytics applications, professional services, patient engagement solutions like Twistle Patient Engagement and Lumeon Care Orchestration, and AI-powered tools. Recent developments include the acquisition of Lumeon Limited in August 2024 and a definitive agreement to acquire Intraprise Health in November 2024. In April 2025, Health Catalyst launched Health Catalyst Ignite Spark™ for community health systems.
HCAT’s Geographic footprint
Health Catalyst is headquartered in South Jordan, Utah, and primarily serves healthcare organizations across the United States. The company has expanding capabilities in the United Kingdom and North America, with additional office locations in Salt Lake City, Boston, Minneapolis, Columbus, and Pittsburgh.
HCAT Corporate Image Assessment
Health Catalyst has maintained a positive brand reputation, receiving recognition from Newsweek as a top healthcare data analytics and digital health company. Modern Healthcare has recognized Health Catalyst for 12 consecutive years as a Best Place to Work in healthcare. The launch of Health Catalyst Ignite Spark™ in April 2025 also contributes positively to its brand.
Ownership
Health Catalyst has significant institutional ownership, with major holders including First Light Asset Management, LLC, BlackRock, Inc., and Vanguard Group Inc. The largest individual shareholder is Mathew Paul Arens, owning 11.03 million shares, representing 15.59% of the company.
Ask Our Expert AI Analyst
Price Chart
$1.62